Literature DB >> 12010122

Cysteine-less glycosylphosphatidylinositol-specific phospholipase C is inhibited competitively by a thiol reagent: evidence for glyco-mimicry by p-chloromercuriphenylsulphonate.

Julie D Stanton1, Mohammad B Rashid, Kojo Mensa-Wilmot.   

Abstract

Glycosylphosphatidylinositol (GPI)-specific phospholipases are highly valuable for studying the structure and function of GPIs. GPI-specific phospholipase C (GPI-PLC) from Trypanosoma brucei and phosphatidylinositol-specific phospholipase C (PI-PLC) from Bacillus cereus are the most widely studied of this class of phospholipases C. Inhibition of protein activity by thiol reagents is indicative of the participation of cysteine residues in biochemical events. The thiol reagent p-chloromercuriphenylsulphonate (pCMPS) inhibits T. brucei GPI-PLC, which has eight cysteine residues. Surprisingly, we found that the activity of B. cereus PI-PLC is also blocked by pCMPS, although the protein does not contain cysteine residues. Inhibition of B. cereus PI-PLC was reversed when pCMPS was size-separated from a preformed pCMPS.PI-PLC complex. In contrast, no activity was recovered when T. brucei GPI-PLC was subjected to a similar protocol. Equimolar beta-mercaptoethanol (beta-ME) reversed the inhibition of PI-PLC activity in a pCMPS.PI-PLC complex. For T. brucei GPI-PLC, however, ultrafiltration of the pCMPS.GI-PLC complex and addition of a large excess of beta-ME was necessary for partial recovery of enzyme activity. Thus T. brucei GPI-PLC is susceptible to inactivation by covalent modification with pCMPS, whereas PI-PLC is not. Kinetic analysis indicated that pCMPS was a competitive inhibitor of PI-PLC when a GPI was a substrate. Curiously, with phosphatidylinositol as substrate, inhibition was no longer competitive. These data suggest that pCMPS is a glyco-mimetic that occupies the glycan binding site of PI-PLC, from where, depending on the substrate, it inhibits catalysis allosterically or competitively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010122      PMCID: PMC1222759          DOI: 10.1042/BJ20020367

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Cysteine residues in the Na+/dicarboxylate co-transporter, NaDC-1.

Authors:  A M Pajor; S J Krajewski; N Sun; R Gangula
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

Review 2.  Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2.

Authors:  M H Gelb; M K Jain; A M Hanel; O G Berg
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

3.  Purification and use of recombinant glycosylphosphatidylinositol-phospholipase C.

Authors:  K Mensa-Wilmot; J C Morris; A al-Qahtani; P T Englund
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

4.  Phosphatidylinositol phospholipase C is activated allosterically by the aminoglycoside G418. 2-deoxy-2-fluoro-scyllo-inositol-1-O-dodecylphosphonate and its analogs inhibit glycosylphosphatidylinositol phospholipase C.

Authors:  J C Morris; L Ping-Sheng; H X Zhai; T Y Shen; K Mensa-Wilmot
Journal:  J Biol Chem       Date:  1996-06-28       Impact factor: 5.157

5.  Serine 228 is essential for catalytic activities of 85-kDa cytosolic phospholipase A2.

Authors:  J D Sharp; R T Pickard; X G Chiou; J V Manetta; S Kovacevic; J R Miller; A D Varshavsky; E F Roberts; B A Strifler; D N Brems
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

6.  Cloning, expression, and mutagenesis of phosphatidylinositol-specific phospholipase C from Staphylococcus aureus: a potential staphylococcal virulence factor.

Authors:  S Daugherty; M G Low
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Glycosyl phosphatidylinositol-specific phospholipase C of Trypanosoma brucei: expression in Escherichia coli.

Authors:  K Mensa-Wilmot; P T Englund
Journal:  Mol Biochem Parasitol       Date:  1992-12       Impact factor: 1.759

8.  Crystal structure of the phosphatidylinositol-specific phospholipase C from Bacillus cereus in complex with myo-inositol.

Authors:  D W Heinz; M Ryan; T L Bullock; O H Griffith
Journal:  EMBO J       Date:  1995-08-15       Impact factor: 11.598

9.  The GPI anchor of cell-surface proteins is synthesized on the cytoplasmic face of the endoplasmic reticulum.

Authors:  J Vidugiriene; A K Menon
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

10.  A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways.

Authors:  K Mensa-Wilmot; J H LeBowitz; K P Chang; A al-Qahtani; B S McGwire; S Tucker; J C Morris
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

View more
  2 in total

1.  Glimepiride reduces CD14 expression and cytokine secretion from macrophages.

Authors:  Victoria Ingham; Alun Williams; Clive Bate
Journal:  J Neuroinflammation       Date:  2014-06-21       Impact factor: 8.322

2.  Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.

Authors:  Clive Bate; Mourad Tayebi; Luisa Diomede; Mario Salmona; Alun Williams
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.